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Influenza is considered a major threat to human health. The current influenza vaccines production system in
embryonated eggs does not satisfy the market needs in cases of pandemic or high seasonal demand.
Furthermore, even though the existent seasonal vaccines are effective to induce protective immunity in healthy
adults, poor immunogenicity in the elderly and early childhood is elicited (Wu et al., 2010). Therefore, there is a
need to develop new generation influenza vaccines produced in robust and flexible production platforms capable
of providing complete immune protection and support the vaccines demand. Virus-like particles (VLP) constitute
a promising alternative to safely elicit a potent immune response against influenza. These particles do not contain
viral genome and their structure mimic influenza virus (Thompson et al., 2015). In this study, a HEK-293SF
inducible stable cell line expressing hemagglutinin (HA) and neuraminidase (NA) of the strain A/PR/8/34 (H1N1)
has been developed. Once the stable cell line, named 293HA/NA, was established, the production of VLPs was
mediated by transient transfection with the plasmid pAdCMV5-GAGGFP that encodes the HIV GAG structural
protein fused with GFP. The transient expression of GAG was efficient to abundantly release the particles in the
culture medium. The VLPs production in 293HA/NA cells using GAGGFP protein as scaffold was studied in 250
mL shake flasks by following the increase of fluorescence in the supernatant (Spectrophotometry) and the
accumulation of HA (Dot-Blot) (Figure 1). The process was successfully operated in a 3L-Bioreactor and at 72h
post-transfection
the
cell
supernatant
was
ultracentrifuged on a 25 % sucrose cushion. High levels
of well-structured influenza GAG-VLPs were obtained
by this production process and their concentration was
estimated by electron microscopy at 5.9*109 VLPs/mL.
The influenza GAG-VLPs were purified by Tangential
Flow Filtration and the concentration of HA was
estimated by three different techniques: Single Radial
Immunodiffusion, Hemagglutination assay and DotBlot. With further optimization, the production system
proposed in this work could be a promising alternative
to support the influenza vaccines manufacturing in the
future.
Figure 1 – Kinetic of expression of GFP and HA during
the production of influenza GAG-VLPs in 293HA/NA
stable cell line.
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